Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards
We’re proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.
The PM360 Trailblazer Awards honor the most impactful initiatives, strategies, and companies driving change in the healthcare industry across eight core categories. This year, our recognition spans multiple disciplines – highlighting our expertise in artificial intelligence (AI), data analytics, patient and healthcare professional (HCP) education, and persistence/adherence programs, as well as our standing as a top industry partner.
Our 2025 PM360 trailblazer award finalist categories
- Artificial Intelligence/Data Analytics Initiative – Inizio Evoke
- Patient/Consumer Education – Inizio Evoke and Gilead Sciences
- HCP Education – Inizio Evoke and Gilead Sciences
- Persistence/Adherence Program – Inizio Engage
- Company of the Year (Supplier to Healthcare Manufacturers) – Inizio Engage
- Best AI/Data Analytics Initiative – Inizio Medical (with Blend)
Driving innovation across healthcare marketing
These finalist recognitions demonstrate how our connected capabilities empower life sciences organizations to achieve greater patient engagement, educational impact, and data-driven decision-making. Our work leverages cutting-edge AI and analytics, compelling creative strategies, and deep scientific expertise to deliver measurable results for our clients and ultimately improve healthcare outcomes.
Looking ahead
We are honored to be recognized alongside such inspiring organizations and partners. These six finalist nominations reflect the passion, creativity, and expertise of our teams across Inizio.
Good luck to all of this year’s finalists – we look forward to celebrating the incredible work shaping the future of healthcare marketing. Stay tuned for the results and follow our updates on LinkedIn.
Jump to a slide with the slide dots.
Inizio appoints Ryan Quigley as CEO to lead next phase of growth
We are delighted to announce the appointment of Ryan Quigley as Chief Executive Officer, effective 9 September 2025.
Read moreAccelerating impact in oncology at ESMO 2025
Meet Inizio at ESMO 2025 in Berlin to explore how oncology expertise and AI-driven insights advance cancer care.
Read moreInizio Medical and Inizio Evoke named finalists at 2025 Fierce Pharma Marketing Awards
We’re proud to announce that our teams across Inizio Medical and Inizio Evoke have been named finalists in three categories.
Read more